Ezetimibe (Zetia, Vytorin) use declining after ENHANCE trial publication in 2008
1. After the publication of the ENHANCE trial results, there was a significant decrease in the number of new initiations ...
1. After the publication of the ENHANCE trial results, there was a significant decrease in the number of new initiations ...
In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Effects ...
In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Loss-of-function ...
1. Statin users had lower baseline Physical Activity Scale for the Elderly (PASE) scores, and the decline in points per year ...
Image: PD In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past ...
Image: PD 1. When paired with statin therapy, evolocumab greatly reduced patient low-density lipoprotein cholesterol (LDL-C) levels compared to placebo ...
Image: PD In this section, we will highlight the key high-impact studies, updates, and analyses published in medicine during the ...
Image: PD 1. From an N-of-1, placebo-controlled, double-blinded crossover trial, no statistically significant difference was found in myalgia between statin ...
Image: PD 1. A mid-intensity statin plus ezetimibe lowered LDL-C more than high-intensity statin monotherapy in patients with either atherosclerotic ...
Image: PD 1. New clinical guidelines from the American College of Cardiology (ACC) and the American Heart Association (AHA) recommend ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.